Cargando…
Natural Products as a Novel Therapeutic Strategy for NLRP3 Inflammasome-Mediated Gout
Gout is the most common form of inflammatory arthritis. It occurs when monosodium urate crystals (MSU) are deposited within joints due to hyperuricemia and persistent elevations of serum uric acid levels. Traditional gout treatment such as urate-lowering therapy is difficult to continue for a long p...
Autores principales: | Lee, Jun Ho, Kim, Hyuk Soon, Lee, Jun-Ho, Yang, Gabsik, Kim, Hong Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967252/ https://www.ncbi.nlm.nih.gov/pubmed/35370689 http://dx.doi.org/10.3389/fphar.2022.861399 |
Ejemplares similares
-
Improvement Effect of Soyeom Pharmacopuncture on Gout via NLRP3 Inflammasome Regulation
por: Kim, Sung Wook, et al.
Publicado: (2022) -
A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer’s and Parkinson’s Disease
por: Lee, Jun Ho, et al.
Publicado: (2021) -
Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout
por: Lee, Hye Eun, et al.
Publicado: (2016) -
A novel strategy for bioactive natural products targeting NLRP3 inflammasome in Alzheimer’s disease
por: Yang, Zhiyou, et al.
Publicado: (2023) -
Loganin Alleviates Gout Inflammation by Suppressing NLRP3 Inflammasome Activation and Mitochondrial Damage
por: Choi, Nuri, et al.
Publicado: (2021)